View this email in your browser ([link removed])
[link removed] May 18, 2026
** HIV Vaccine Awareness Day Resources and Perspectives
------------------------------------------------------------
Dear Advocate,
On this HIV Vaccine Awareness Day, AVAC is sharing resources and perspectives on the HIV vaccine pipeline, the science behind neutralizing antibodies, the state of bNAb combinations, and the broader state of HIV research amid the destruction and devastation of science and the HIV response.
While an HIV vaccine remains elusive, in the current environment of threats to science, vaccines and the global HIV/AIDS response, HVAD serves as an important moment to re-commit to HIV vaccine R&D and the essential role of discovery science as part of a comprehensive, integrated and sustained response.
Read on for resources to support your advocacy.
roadmap
[link removed]
** The People’s Research Agenda (PRA): Preventive Vaccines
------------------------------------------------------------
AVAC and partners' PRA outlines the path forward for HIV vaccine research and development, identifying critical gaps from the need for a shared target product profile to stronger coordination and sustained political support to accelerate progress.
read more ([link removed])
INFOGRAPHIC
[link removed]
** HIV Vaccine Clinical Trials Pipeline
------------------------------------------------------------
This graphic summarizes the state of HIV vaccine research, detailing the different immunological approaches in clinical trials, the specific candidates being studied, and the collaborative networks of funders and developers working toward a safe and durable vaccine.
VIEW INFOGRAPHIC ([link removed])
infographic
[link removed]
HIV vaccine research today is focused on early-stage, iterative discovery approaches ([link removed]) designed to induce broadly neutralizing antibodies (bNAbs) and T-cell responses. This graphic provides an overview of the combinations of broadly neutralizing antibodies (bNAbs) under investigation in early clinical studies for HIV prevention.
download the infographic ([link removed])
podcast
[link removed]
** An HIV Vaccine—Looking into the future with Nina Russell
------------------------------------------------------------
Last HVAD we recorded a podcast with Nina Russell of the Gates Foundation exploring why an HIV vaccine remains essential alongside the scale up of PrEP, unpacking the science, the challenges and what it will take to achieve a durable end to the epidemic. She notes: “It's the science that gives me the most hope...We've seen, over and over again, and COVID was a great example of this, that the science that's been coming out of the HIV vaccine field has been driving innovation across sectors in global health.”
listen now [link removed]
Additional Resources
• HIV-Specific Neutralizing Antibodies by Target ([link removed]) , infographic
• Evolving Strategies for an HIV Vaccine: In conversation with Katy Stephenson, ([link removed]) archived podcast
• Research Fundamentals: An HIV Vaccine — What’s the challenge and what’s the science?, ([link removed]) archived podcast
The message this HIV Vaccine Awareness Day is simple: “Vaccines work; science matters; and the path to ending HIV must include continued investment in the research that will make an HIV vaccine possible.”
In solidarity,
AVAC
Follow us @hivpxresearch ([link removed])
[link removed] [link removed] [link removed]
Share this issue ([link removed])
AVAC Global Advocacy for HIV Prevention
+1 212 796 6423
[email protected] (mailto:
[email protected]) www.avac.org ([link removed])
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences ([link removed]) | Unsubscribe ([link removed])
